flaviolin has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goswami, D; Parmar, P; Patel, BV; Rao, P; Rawal, RM; Saraf, M; Shukla, A | 1 |
1 other study(ies) available for flaviolin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Proposing a fungal metabolite-flaviolin as a potential inhibitor of 3CL
Topics: COVID-19; Fungi; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Naphthoquinones; Protease Inhibitors; SARS-CoV-2 | 2022 |